Correlation Between Beta Drugs and Clean Science
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Clean Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Clean Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Clean Science and, you can compare the effects of market volatilities on Beta Drugs and Clean Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Clean Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Clean Science.
Diversification Opportunities for Beta Drugs and Clean Science
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Beta and Clean is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Clean Science and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clean Science and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Clean Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clean Science has no effect on the direction of Beta Drugs i.e., Beta Drugs and Clean Science go up and down completely randomly.
Pair Corralation between Beta Drugs and Clean Science
Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.74 times more return on investment than Clean Science. However, Beta Drugs is 1.74 times more volatile than Clean Science and. It trades about 0.1 of its potential returns per unit of risk. Clean Science and is currently generating about -0.02 per unit of risk. If you would invest 139,720 in Beta Drugs on November 7, 2024 and sell it today you would earn a total of 61,320 from holding Beta Drugs or generate 43.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.19% |
| Values | Daily Returns |
Beta Drugs vs. Clean Science and
Performance |
| Timeline |
| Beta Drugs |
| Clean Science |
Beta Drugs and Clean Science Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beta Drugs and Clean Science
The main advantage of trading using opposite Beta Drugs and Clean Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Clean Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clean Science will offset losses from the drop in Clean Science's long position.| Beta Drugs vs. Elin Electronics Limited | Beta Drugs vs. Salzer Electronics Limited | Beta Drugs vs. Clean Science and | Beta Drugs vs. TVS Electronics Limited |
| Clean Science vs. Parag Milk Foods | Clean Science vs. Sudarshan Chemical Industries | Clean Science vs. Fertilizers and Chemicals | Clean Science vs. Foods Inns Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |